• MH3 COST-EFFECTIVENESS OF LONG-ACTING METHYLPHENIDATE FOR TREATMENT OF ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS IN FINLAND- AN EVALUATION BASED UPON A RANDOMIZED CLINICAL TRIAL (RCT)

    Nov 1, 2008, 00:00

  • PIN20 COST-EFFECTIVENESS OF SURGICAL INTERVENTION FOR THERAPY-INDUCED FACIAL LIPOATROPHY IN HIV-INFECTED PATIENTS

    Nov 1, 2008, 00:00

  • PHP59 LABEL CLAIMS BASED ON PATIENT REPORTED OUTCOMES IN EMEA AND FDA APPROVALS SINCE 2000

    Nov 1, 2008, 00:00

  • PRS34 QUALITY OF LIFE DURING ACUTE EXACERBATIONS OF COPD- COMPARING EQ-5D, SF-12 AND SGRQ

    Nov 1, 2008, 00:00

  • PMS55 EURO QOL (EQ-5D) BASED QOL (QUALITY OF LIFE) IN 5,023 JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) PATIENTS IN AN OBSERVATIONAL COHORT IORRA

    Nov 1, 2008, 00:00

  • PG130 A EUROPEAN CROSS-SECTIONAL STUDY TO EVALUATE SYMPTOM BURDEN AND CLINICAL MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (RANGE-GREECE)

    Nov 1, 2008, 00:00

  • PMH42 HEALTH-RELATED QUALITY OF LIFE OF MARRIED, WORKING WOMEN WITH CHILDREN (SUPERWOMAN SYNDROME) IN KOREA

    Nov 1, 2008, 00:00

  • PHC3 COST AND QUALITY IMPROVEMENTS ASSOCIATED WITH MINIMALLY INVASIVE SURGERY (MIS) TOTAL HIP ARTHROPLASTY (THA)

    Nov 1, 2008, 00:00

  • PCV72 COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL

    Nov 1, 2008, 00:00

  • PMC53 IS UTILITY A LINEAR FUNCTION OF LIFETIME?

    Nov 1, 2008, 00:00

  • PHP35 PHARMACEUTICAL EXPENDITURE IN GREECE 1980-2006

    Nov 1, 2008, 00:00

  • PMS53 PUBLIC HEALTH OBJECTIVE- THE QUALITY OF LIFE OF SUFFERERS OF OSTEOARTHRITIS FINALLY TAKEN INTO CONSIDERATION

    Nov 1, 2008, 00:00

  • PUK15 ASSESSMENT OF THE BENEFITS OF TIME SAVINGS ACHIEVED BY ONCE MONTHLY INJECTION OF ERYTHROPOIETIN STIMULATING AGENTS (ESA) ON ANAEMIA MANAGEMENT IN HAEMODIALYSIS CENTRES

    Nov 1, 2008, 00:00

  • MH4 HEALTH SERVICE EXPENDITURES FOR CHILDREN AND ADOLESCENTS WITH AND WITHOUT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GERMANY-IMPACT OF COEXISTING CONDITIONS

    Nov 1, 2008, 00:00

  • PMH32 A GPRD STUDY OF HEALTH CARE COST ASSOCIATED WITH DIFFERENT FIRST-LINE ANTIDEPRESSANT TREATMENTS IN SEVERE DEPRESSION

    Nov 1, 2008, 00:00

  • PIN9 BUDGET IMPACT ANALYSIS OF INTRODUCING ROUTINE VACCINATION WITH A QUADRIVALENT HPV-VACCINE IN NORWAY

    Nov 1, 2008, 00:00

  • PMC11 IMPROVING PROBABILISTIC SENSITIVITY ANALYSIS (PSA) IN THE TREATMENT OF UNCERTAINTY COSTS USING MCMC

    Nov 1, 2008, 00:00

  • PCV5 A REALWORLD COMPARISON OF COMBINED LIPID TARGET ATTAINMENT BETWEEN COMBINATION NIACIN EXTENDED-RELEASEEZETIMIBE

    Nov 1, 2008, 00:00

  • PND23 RELATIONSHIP BETWEEN CHANGES IN EQ-5D DERIVED UTILITY SCORES AND CHANGES IN IRLS SUM SCORES FROM A MAPPING EXERCISE IN TWO PHASE III CLINICAL TRIALS

    Nov 1, 2008, 00:00

  • PMC19 COST-EFFECTIVENESS ANALYSES OF BEHAVIORAL INTERVENTIONS- TOWARDS A MORE REALISTIC COST-EFFECTIVENESS RATIO BY INCLUDING INTERMEDIATE OUTCOME MEASURES

    Nov 1, 2008, 00:00

  • QL3 ACCESS TO HEALTH-RELATED QUALITY OF LIFE (HRQL) INSTRUMENTS AND THEIR TRANSLATIONS IN THE LIGHT OF EMEA RECOMMENDATIONS

    Nov 1, 2008, 00:00

  • PSS5 IMPACT OF COMPLIANCE ON INTRA-OCULAR PRESSURE (IOP) CONTROL IN GLAUCOMA PATIENTS

    Nov 1, 2008, 00:00

  • PUK2 IN GREECE, INCREASING THE UTILIZATION OF PERITONEAL DIALYSIS THERAPY MAY REDUCE OVERALL DIALYSIS EXPENDITURES

    Nov 1, 2008, 00:00

  • PG116 DIRECT MEDICAL COSTS OF GERD AND ASSOCIATED FACTORS

    Nov 1, 2008, 00:00

  • PMS52 THE QUALITY OF LIFE OF SUFFERERS OF OSTEOARTHRITIS- THE IMPACT OF TREATMENT

    Nov 1, 2008, 00:00

  • PMH8 TOLERABILITY OF ONCE-DAILY EXTENDED RELEASE QUETIAPINE COMPARED TO QUETIAPINE IMMEDIATE RELEASE IN THE TREATMENT OF ACUTE BIPOLAR DISORDER- AN ADJUSTED INDIRECT COMPARISON

    Nov 1, 2008, 00:00

  • PRS15 ESTIMATING EXCESS COSTS OF POPULATION-BASED CASES WITH MILD COPD-RESULTS FROM THE KORA F3 STUDY

    Nov 1, 2008, 00:00

  • PCN64 SHIFT OF PUBLIC HEALTH CARE EXPENDITURES FOR PALLIATIVE CANCER PATIENTS FROM INPATIENT TO OUTPATIENT EFFECTED BY HOME CARE SUPPORT TEAMS PROVIDED BY A UNIVERSITY HOSPITAL IN AUSTRIA

    Nov 1, 2008, 00:00

  • PCN102 THE BURDEN OF RENAL CELL CANCER- A RETROSPECTIVE LONGITUDINAL STUDY ON OCCURRENCE, OUTCOMES AND COST USING AN ADMINISTRATIVE CLAIMS DATABASE

    Nov 1, 2008, 00:00

  • PUK17 ESTIMATING THE QUALITY OF LIFE IMPACTS OF TOLTERODINE AND TAMSULOSIN TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND OVERACTIVE BLADDER

    Nov 1, 2008, 00:00

  • PSS53 A TOPIC DERMATITIS IN PAEDIATRIC PATIENTS- COMMON CAREGIVER BEHAVIOURWHEN FACING THE DIFFERENT DISEASE PRESENTATIONS OR LESION SEVERITY. ELIBROT STUDY

    Nov 1, 2008, 00:00

  • PCN103 HETEROGENEITY IN THE APPROACH TAKEN TO CONDUCTING CHART AUDITS IN AUSTRALIAN HOSPITALS

    Nov 1, 2008, 00:00

  • PCN7 ANALYSIS AND CATEGORISATION OF DRUG-RELATED PROBLEMS ASSOCIATED WITH SYSTEMIC BREAST CANCER THERAPY

    Nov 1, 2008, 00:00

  • PCN78 QUALITY OF LIFE (QOL) IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) IN TREATMENT WITH PLACITAXEL WITH/WITHOUT BEVACIZUMAB, RELATED WITH TREATMENT RESPONSE (REMISSION AND PROGRESSION)

    Nov 1, 2008, 00:00

  • PHP54 ANTIBIOTICS CONSUMPTION IN THE REPUBLIC OF SERBIA IN 2004, 2005, 2006 AND 2007

    Nov 1, 2008, 00:00

  • PHC10 PROPHYLAXIS WITH RIVAROXABAN AGAINST VENOUS THROMBOEMBOLISM (VTE)-A COST-CONSEQUENCE ANALYSIS FROM THE PERSPECTIVE OF THE ITALIAN HEALTH CARE SERVICE

    Nov 1, 2008, 00:00

  • PDB35 COST-UTILITY ANALYSIS OF BIPHASIC INSULIN ASPART VERSUS HUMAN INSULIN IN TYPE 2 DIABETES MELLITUS PATIENTS TREATED IN TIER III HOSPITALS IN BEIJING, CHINA- A LONGTERM OUTCOMES MODEL EVALUATION FROM THE IMPROVE OBSERVATIONAL STUDY

    Nov 1, 2008, 00:00

  • PHC6 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN SPAIN

    Nov 1, 2008, 00:00

  • PSY63 PATIENT-REPORTED OUTCOMES (PROS) AND ECONOMICS OF NEUROPATHIC PAIN IN GERMANY

    Nov 1, 2008, 00:00

  • CV4 COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN STABLE ANGINA PATIENTS IN THE NETHERLANDS

    Nov 1, 2008, 00:00

  • PHP44 IN EQUALITIES IN THE FINANCING OF DRUGS AMONG AUTONOMOUS REGIONS IN SPAIN

    Nov 1, 2008, 00:00

  • PCV103 TECHNOLOGICAL INNOVATION AND THE DECISION-MAKING PROCESS IN ITALIAN HOSPITALS

    Nov 1, 2008, 00:00

  • PHP41 ANALYSIS OF CLINICAL PHARMACISTS INTERVENTIONS IN A UNIVERSITY TEACHING HOSPITAL IN OMAN

    Nov 1, 2008, 00:00

  • PDB53 VALIDATION OF THE HUMAN GROWTH HORMONE PREFERENCE AND SATISFACTION QUESTIONNAIRE (HGH-PSQ)

    Nov 1, 2008, 00:00

  • PRS4 SUB-ACUTE LACK OF ASTHMA CONTROL AS A PREDICTOR OF ASTHMA EXACERBATION IN A MANAGED CARE POPULATION

    Nov 1, 2008, 00:00

  • PHC9 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN THE UK

    Nov 1, 2008, 00:00

  • PMC8 DESIGN AND REPORTING TRENDS IN PIGGY-BACK ECONOMIC TRIALS

    Nov 1, 2008, 00:00

  • PSS12 SENSITIVE SKINS IN PORTUGAL- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • PRS30 HOW CONGRUENT ARE PATIENT AND CLINICIAN MODELS OF ASTHMA CONTROL?-PRELIMINARY FINDINGS FROM A QUALITATIVE STUDY

    Nov 1, 2008, 00:00

  • PIN32 COSTS OF INTERMITTENT VERSUS CONTINUOUS ANTIRETROVIRAL THERAPY IN PATIENTS WITH CONTROLLED HIV INFECTION.A SUBSTUDY OF THE ANRS 106 WINDOW TRIAL

    Nov 1, 2008, 00:00

  • PSY3 PREVALENCE OF METABOLIC ABNORMALITIES AMONG OBESE ADULTS IN KOREA

    Nov 1, 2008, 00:00

  • PSY61 INCREMENTAL SAVINGS ASSOCIATED WITH A DECREASE IN ANTIDEPRESSANT MEDICATIONS FOLLOWING BARIATRIC SURGERY IN WESTERN NEWYORK

    Nov 1, 2008, 00:00

  • PCN23 COST EFFECTIVENESS OF CLODRONATE AND ZOLENDRONATE FOR THE TREATMENT OF METASTATIC BONE DISEASE IN BRAZIL- PUBLIC HEALTH PERSPECTIVE

    Nov 1, 2008, 00:00

  • PCV95 SOCIODEMOGRAPHIC AND CARDIOVASCULAR RISK FACTORS INFLUENCES ON EQ-5D SOCIAL PREFERENCES SCORES AND SELF-REPORTED HEALTH- A GENERAL POPULATION SURVEY IN ARGENTINA

    Nov 1, 2008, 00:00

  • PDB48 NOT ALL ROADS LEAD TO ROME-A REVIEW OF QUALITY OF LIFE MEASUREMENT IN DIABETES

    Nov 1, 2008, 00:00

  • PCN109 DEALING WITH QUALITY OF LIFE MISSING DATA IN A SINGLE ARM STUDY. COMPARISON OF MULTIPLE IMPUTATION METHODS

    Nov 1, 2008, 00:00

  • PUK19 PSYCHOMETRIC EVALUATION OF THE KHQ IN TEN LANGUAGES

    Nov 1, 2008, 00:00

  • PHP34 COSTS ASSOCIATED TO ADDITIONAL TEMPORAL SICK LEAVE DAYS IN THE IMSS

    Nov 1, 2008, 00:00

  • PIN2 ASSESSING ANTIMICROBIAL SUCCESS RATES IN THE TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI)-A BAYESIAN META-ANALYSIS

    Nov 1, 2008, 00:00

  • PDB30 INSTIGATE STUDY (INSULIN TITRATION; GAINING AN UNDERSTANDING OF THE BURDEN OF TYPE 2 DIABETES IN EUROPE)- HEALTH CARE RESOURCE UTILIZATION AND COSTS WITHIN THE FIRST 6 MONTHS OF INSULIN THERAPY-FRENCH DATA

    Nov 1, 2008, 00:00

  • PSY17 PRECISE STUDY- BASELINE ANALYSIS OF A COST EFFECTIVENESS STUDY ON FAILED BACK SURGERY SYNDROME

    Nov 1, 2008, 00:00

  • PCV118 ADVANCING SYNCOPE DIAGNOSISTHROUGH IMPLANTABLE LOOP RECORDERS (ILRS) IN SWEDEN- COST-EFFECTIVENESS ANALYSIS OF NEW DIAGNOSTIC STRATEGIES

    Nov 1, 2008, 00:00

  • PCV6 EFFECTIVENESS OF CLOPIDOGREL IN ADDITION TO ASPIRIN COMPARED TO ASPIRIN ALONE AFTER ACUTE CORONARY SYNDROME

    Nov 1, 2008, 00:00

  • PSY55 PAIN MANAGEMENT IN THAILAND- IMPLICATION FOR BETTER PATIENT EDUCATION

    Nov 1, 2008, 00:00

  • PCN50 COST-MINIMIZATION ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL OR PEMETREXED AS A SECOND-LINE TRETAMENT OF ADVANCED NON-SMALL LUNG CANCER (NSCLC) IN THE CONDITIONS OF THE CZECH REPUBLIC

    Nov 1, 2008, 00:00

  • PIN37 GENITAL WARTS IN ITALY- A COST OF ILLNESS ANALYSIS

    Nov 1, 2008, 00:00

  • PMH59 MODELLING THE ANTIDEPRESSANTS MARKET BEHAVIOUR AFTER PATENT EXPIRIES

    Nov 1, 2008, 00:00

  • PG127 PSYCHOMETRIC VALIDATION OF TRANSLATION TO SPANISH OF THE REFLUX DISEASE QUESTIONNAIRE (RDQ) AND GASTROINTESTINAL IMPACT SCALE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)

    Nov 1, 2008, 00:00

  • PSS35 COST UTILITY OF BILATERAL COCHLEAR IMPLANT

    Nov 1, 2008, 00:00

  • PIN36 SOCIO-ECONOMIC IMPACT OF AVIAN INFLUENZA IN SOUTH-EAST ASIA AND NEIGHBOURING HIGH RISK COUNTRIES

    Nov 1, 2008, 00:00

  • PCN77 DERIVING UTILITY VALUES FROM THE GENERAL POPULATION FOR INDUCTION CHEMOTHERAPY ADMINISTERED BEFORE CONCURRENT CHEMOTHERAPY-RADIATION THERAPY IN THE TREATMENT OF HEAD AND NECK CANCER

    Nov 1, 2008, 00:00

  • PCV33 COST OF OUTPATIENT HYPERTENSION PHARMACOTHERAPY-COMPARATIVE STUDY BETWEEN BULGARIA AND SERBIA

    Nov 1, 2008, 00:00

  • PMS45 OUTPATIENT MEDICAL MANAGEMENT OF FIBROMYALGIA IN FRANCE COMPARED TO THE UNITED KINGDOM

    Nov 1, 2008, 00:00

  • PCV41 COST EFFECTIVENESS OF IMPLANTABLE LOOP RECORDER SYSTEM (REVEAL DX) FROM THE SPANISH NHS PERSPECTIVE

    Nov 1, 2008, 00:00

  • MH2 THE SUSTAINED DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM CHILDHOODTO ADULTHOOD- A MEDICAID STUDY

    Nov 1, 2008, 00:00

  • PCN24 PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH BORTEZOMIB FOR THE TREATMENT OF RELAPSED MULTIPLE MYELOMA-A COST-EFFECTIVENESS STUDY FOR SCOTLAND

    Nov 1, 2008, 00:00

  • PG131 GENDER, AGE AND BODY MASS-RELATED DIFFERENCES IN THE IMPACT OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) SYMPTOMS IN PRIMARY CARE PATIENTS ASSESSED BY THE GASTROINTESTINAL IMPACT SCALE (GIS)

    Nov 1, 2008, 00:00

  • MH5 EFFECT OF A NURSE TELEPHONE FOLLOW-UP ON THERAPEUTIC ADHERENCE OF PATIENTS WITH SCHIZOPHRENIA

    Nov 1, 2008, 00:00

  • PMH20 ECONOMIC EVALUATION OF PALIPERIDONE ER FOR THE TREATMENT OF SCHIZOPHRENIA IN THE CONTEXT OF BRAZILIAN PUBLIC HEALTH CARE SYSTEM

    Nov 1, 2008, 00:00

  • PSS42 PSORIASIS AND THERMAL THERAPY- EVALUATION OF MEDICAL SERVICE

    Nov 1, 2008, 00:00

  • PCV57 ESTIMATING THE NUMBER AND COST OF CARDIOVASCULAR EVENTS AVOIDED BY TREATING TO ALTERNATIVE LDL-C TARGETS- IS LOWER BETTER?

    Nov 1, 2008, 00:00

  • PIN25 COST-EFFECTIVENESS OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INCLUDING HERD PROTECTION IN TURKEY

    Nov 1, 2008, 00:00

  • PRS20 SYSTEMATIC REVIEW OF FIXED-DOSE COMBINATIONS AND UNIT-OF-USE PACKAGING IN PATIENTS WITH HYPERTENSION, DYSLIPIDEMIA, AIDS, ASTHMA AND DIABETES TYPE 2

    Nov 1, 2008, 00:00

  • PDB22 COST-EFFECTIVENESS OF INSULIN GLARGINE COMPARED TO INSULIN DETEMIR FOR TYPE 1 (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING

    Nov 1, 2008, 00:00

  • PND25 EVALUATION OF A BRIEF DEMENTIA SCREENING TEST FOR PARKINSONS DISEASE (PD-BDST) IN A CLINICAL PRACTICE SETTING

    Nov 1, 2008, 00:00

  • PHP46 CATEGORISING RESEARCH- WHERE IS THE FOCUS?

    Nov 1, 2008, 00:00

  • PHP16 OUTHOSPITAL DRUG CONSUMPTION IN MONTENEGRO IN 2007

    Nov 1, 2008, 00:00

  • PMS64 DIFFERENCES IN QUALITY OF LIFE ACCORDING TO THE REPLACED JOINT

    Nov 1, 2008, 00:00

  • QL10 DEVELOPMENT AND VALIDATION OF THE SATISFACTION WITH MEDICATION QUESTIONNAIRE (SAT-Q) IN PATIENTS WITH CHRONIC DISEASE

    Nov 1, 2008, 00:00

  • PMS47 USING HAQTO ESTIMATE HUI3 AND EQ-5D UTILITY VALUES IN SPANISH RHEUMATOID ARTHRITIS PATIENTS

    Nov 1, 2008, 00:00

  • PSS40 RESPONSE SHIFT IN A RANDOMIZED CONTROLLED TRIAL OF LOWVISION CARE FOR PATIENTS WITH AGE-RELATED MACULOPATHY

    Nov 1, 2008, 00:00

  • PCV100 METFORMIN FOR THE TREATMENT OF METABOLIC DISTURBANCES AND CARDIOVASCULAR RISK FACTORS INWOMEN WITH POLYCYSTIC OVARY SYNDROME- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2008, 00:00

  • PRS8 TOTAL COSTS OF TOBACCO FOR SOCIETY-WHAT ARE THE RETURNS ON INVESTMENTS FOR DIFFERENT GOVERNMENTAL INTERVENTIONS?

    Nov 1, 2008, 00:00

  • PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND

    Nov 1, 2008, 00:00

  • PCV40 COST-EFFECTIVENESS OF TARGETING MULTIPLE LIPID PARAMETERS (LDL-C, HDL-C, TG) WITH NIASPANVERSUS A SINGLE LIPID PARAMETER (LDL-C) WITH ZETIA IN PATIENTS RECEIVING ON-GOING STATIN THERAPY

    Nov 1, 2008, 00:00

  • PSS1 RISK OF PSYCHIATRIC DISORDERS AND HEALTH CARE EXPENDITURES AMONG PATIENTS WITH MODERATE TO SEVERE PSORIASIS

    Nov 1, 2008, 00:00

  • PUK16 EXPLORING THE IMPACT OF CHANGES IN NEUROGENIC URINARY INCONTINENCE FREQUENCY AND CONDITION SPECIFIC QUALITY OF LIFE ON PREFERENCE-BASED OUTCOMES

    Nov 1, 2008, 00:00

  • PSY34 COSTS AND PATIENT-REPORTED OUTCOMES (PRO) IN GERMAN PATIENTS WITH CHRONIC KNEE AND HIP PAIN

    Nov 1, 2008, 00:00

  • PCV102 COST-EFFECTIVENESS OF MANAGING ORAL ANTICOUAGULATION (OAC) AFTER CATHETER ABLATION FOR A TRIAL FIBRILLATION (PAAF) WITH IMPLANTABLE CARDIAC MONITORS (ICMS)

    Nov 1, 2008, 00:00

  • PMC46 SHOULDWE BE CONSIDERING COMPONENTS OF SOCIAL COGNITION MODELS TO IMPROVE ADHERENCE TO IMMUNOSUPPRESSION MEDICATION?

    Nov 1, 2008, 00:00

  • PDB11 POTENTIAL IMPACT OF LIPID CONTROL AND SUBSEQUENT CARDIOVASCULAR (CV) RISK REDUCTION INT2DM POPULATION TREATED WITH ORAL COMBINATION THERAPY (OCT) RECAP-DM STUDY

    Nov 1, 2008, 00:00

  • IN4 ACHIEVING SUSTAINED VIROLOGIC RESPONSE WITH CHRONIC HEPATITIS CTREATMENT IS ASSOCIATED WITH IMMEDIATE HEALTH CARE UTILIZATION BENEFITS IN EUROPE

    Nov 1, 2008, 00:00

  • PHP5 HEALTH LITERACY-AN ECONOMIC PERSPECTIVE- A SYSTEMATIC REVIEW

    Nov 1, 2008, 00:00

  • PHC2 IMPACT OF LOCAL HAEMOSTATIC AGENTS IN ABDOMINAL SURGERY ON HOSPITAL BUDGET

    Nov 1, 2008, 00:00

  • PDB50 CONCEPTUAL DEVELOPMENT OF A PATIENT SELF-ASSESSMENT TOOL TO IMPROVE PATIENT-CLINICIAN COMMUNICATION ON THE DAILY MANAGEMENT OF TYPE 2 DIABETES

    Nov 1, 2008, 00:00

  • HT4 HEALTH TECHNOLOGY ASSESSMENTS- ARE THEY RELEVANT TO CLINICAL PRACTICE?

    Nov 1, 2008, 00:00

  • PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS- POOLED RESULTS FROMTHREE PHASE 3 STUDIES

    Nov 1, 2008, 00:00

  • PCASE4 BRIDGING THE GAP OF EVIDENCE AND COSTEFFECTIVENESS- THE PRAGMATIC APPROACH USING ECONOMIC MODELLING TO ASSESS THE COSTEFFECTIVENESS FOR ASSISTIVE TECHNOLOGIES (AT) IN THE UK-BOTH PRE-AND POSTMARKETED

    Nov 1, 2008, 00:00

  • PND29 EFFICIENCY PROFILE IN THE NEUROLOGICAL REFERRALS EFFECTUATE REFERENCE SPECIALISTS- USE CASE-MIX SYSTEM ADJUSTED CLINICAL GROUPS

    Nov 1, 2008, 00:00

  • PDB6 EFFECTS OF PIOGLITAZONE AND ROSIGLITAZONE ON GLUCOSE AND THE CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES- A META-ANALYSIS

    Nov 1, 2008, 00:00

  • PMS16 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS-BUDGET IMPACT ANALYSIS ON POLISH NATIONAL HEALTH FUND

    Nov 1, 2008, 00:00

  • PSY49 PATIENT-REPORTED OUTCOMES, HEALTH CARE RESOURCES UTILIZATION, WORK PRODUCTIVITY AND THEIR ASSOCIATED COSTS IN PATIENTS WITH NEUROPATHIC PAIN- A CASE CONTROL COMPARISON OF TREATMENT WITH PREGABALIN VERSUS GABAPENTIN IN ROUTINE MEDICAL ...

    Nov 1, 2008, 00:00

  • PMH61 ADULTS WITH ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) IN GERMANY-PREVALENCE, COMORBIDITIES AND PHARMACOTHERAPY IN PRACTICE

    Nov 1, 2008, 00:00

  • AR4 MEASUREMENT AND RATES OF ADHERENCE TO BIOLOGICS IN PATIENTS WITH RHEUMATOID ARTHRITIS

    Nov 1, 2008, 00:00

  • PHP4 PATIENT PREFERENCES TOWARD HEALTH SERVICES PROVIDED BY THE GENERAL PRACTIONER

    Nov 1, 2008, 00:00

  • PMC10 PREVALENT AND MULTIPLE FUTURE INCIDENT COHORTS IN COST-EFFECTIVENESS ANALYSIS

    Nov 1, 2008, 00:00

  • PRS38 DEVELOPMENT OF EXPLICIT APPROPRIATENESS CRITERIA FOR THE INDICATION OF ADMISSION FROM PATIENTS WITH ACUTE COPD EXACERBATION

    Nov 1, 2008, 00:00

  • PSS15 SENSITIVE SKINS IN SPAIN- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • PMC37 CHALLENGES OF TRANSLATING AND LINGUISTICALLY VALIDATING PRO MEASURES INTO SLAVIC LANGUAGES

    Nov 1, 2008, 00:00

  • PCN75 AN UPDATED GEOGRAPHIC SUBPOPULATION ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) ENROLLED IN A PHASE III TRIAL OF SUNITINIB VERSUS INTERFERON-ALFA

    Nov 1, 2008, 00:00

  • PCV81 AN ECONOMIC EVALUATION OF THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY IN TERMS OF OPTIMAL LIPID VALUE ATTAINMENT

    Nov 1, 2008, 00:00

  • PG16 THE MANAGEMENT OF GASTRO OESOPHAGEAL REFLUX DISEASE IN SPAIN- A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUETO A GREATER PANTOPRAZOL IV PENETRATION

    Nov 1, 2008, 00:00

  • PSS39 QUALITY OF LIFE IN MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN

    Nov 1, 2008, 00:00

  • PCV46 COST-EFFECTIVENESS OF CLOPIDOGREL IN MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION- A SPANISH MODEL BASED ON THE CLARITY AND COMMITTRIALS

    Nov 1, 2008, 00:00

  • CN6 COST-EFFECTIVENESS OF A HUMAN PAPILLOMAVIRUS VACCINE IN REDUCING THE RISK OF CERVICAL CANCER IN IRELAND USING ATRANSMISSION DYNAMIC MODEL

    Nov 1, 2008, 00:00

  • PIH1 CHANGES IN PELVIC FLOOR MUSCLE STRENGTH, ITS DURATION AND ITS RELAXATION ABILITY DURING PREGNANCY

    Nov 1, 2008, 00:00

  • PMC44 THE SIGNIFICANCE OF PATIENT-REPORTED OUTCOMESTO FACILITATE MARKET ACCESS DURING A PRODUCT LIFECYCLE

    Nov 1, 2008, 00:00

  • PHP47 ASSOCIATION BETWEEN HEALTH-RELATED QUALITY OF LIFE AND HEALTH SERVICE UTILIZATION AMONG PRIMARY CARE PATIENTS

    Nov 1, 2008, 00:00

  • PHP8 ADVERSE DRUG REACTIONS IN GERMANY- COST ANALYSIS OF INTERNAL MEDICINE HOSPITALIZATIONS

    Nov 1, 2008, 00:00

  • PSY52 QUALITY OF LIFE IN RUSSIAN PATIENTS WITH HEREDITARY COAGULOPATHIES. INTERMEDIATE RESULTS

    Nov 1, 2008, 00:00

  • QL8 COMPARISON OF CANCER-RELATED FATIGUE USING A ONE- VERSUS FOUR-WEEK RECALL PERIOD

    Nov 1, 2008, 00:00

  • PCV76 THE KOREAN INDIVIDUAL-MICROSIMULATION MODEL FOR CARDIOVASCULAR HEALTH INTERVENTIONS (KIMCHI)

    Nov 1, 2008, 00:00

  • PMS28 COST OF RHEUMATOID ARTHRITIS MODEL PER LEVEL OF DISEASE ACTIVITY IN FRANCE

    Nov 1, 2008, 00:00

  • PMC6 SOCIAL DISCOUNTING IN THE ECONOMIC EVALUATION OF HEALTH CARE PROGRAMMES

    Nov 1, 2008, 00:00

  • PMC18 CONCEPTUALISING DISEASE- BUILDING UNIFYING MODELS TO SUPPORT THE DEVELOPMENT OF PROS AND COST-EFFECTIVENESS ANALYSES. A CASE STUDY IN ALZHEIMER-S DISEASE (AD)

    Nov 1, 2008, 00:00

  • EE1 DISCRETE CHOICE EXPERIMENTS OF COMPLEX HEALTH CARE DECISIONS- DOES HIERARCHICAL INFORMATION INTEGRATION OFFER A SOLUTION?

    Nov 1, 2008, 00:00

  • PSS18 SENSITIVE SKINS IN SWITZERLAND- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • PG125 ESTABLISHING THE RELATIONSHIP BETWEENTHE ULCERATIVE COLITIS DISEASE ACTIVITY INSTRUMENT (UCDAI) AND PATIENT HEALTH RELATED QUALITY OF LIFE FROM A LARGE RANDOMISED CONTROLLED TRIAL

    Nov 1, 2008, 00:00

  • PMS19 COST-EFFECTIVENESS OF USING ETANERCEPT AS FIRST LINE IN SEVERE AND HIGHLY ACTIVE RHEUMATOID ARTHRITIS (RA)

    Nov 1, 2008, 00:00

  • MH8 DIRECT COST OF TREATING PATIENTS WITH SCHIZOPHRENIA IN GREECE- REAL-WORLD DATA FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR)

    Nov 1, 2008, 00:00

  • DB2 IMPACT OF OVERWEIGHT OR OBESITY ON TREATMENT COSTS IN PATIENTS WITH DIABETES IN THE USA- QUANTILE REGRESSION APPROACH

    Nov 1, 2008, 00:00

  • PHP37 HEALTH EXPENDITURES AND PERFORMANCE.THE ANLISIS OF THE FINANCIAL GAPS IN BUENOS AIRES PROVINCE

    Nov 1, 2008, 00:00

  • PMH38 CAN PATIENTS WITH SCHIZOPHRENIA COMPLETE A CONJOINT ANALYSIS? EVIDENCE FROM GERMANY

    Nov 1, 2008, 00:00

  • PMH1 PREVALENCE OF TIC DISORDERS AND COEXISTENCE WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN A GERMAN COMMUNITY SAMPLE

    Nov 1, 2008, 00:00

  • PIN44 IMPACT OF ETRAVIRINE ON HOSPITALIZATIONS AND HOSPITAL RELATED COSTS IN BELGIUM- 48-WEEK FINDINGS FROM POOLED DUETTRIALS

    Nov 1, 2008, 00:00

  • PG126 DERIVING PREFERENCE BASED UTILITIES FOR CD AND UC PATIENTS- CONVERTING IBDQ INTO EQ-5D UTILITIES

    Nov 1, 2008, 00:00

  • PSS43 A TOPIC DERMATITIS AND THERMAL THERAPY- EVALUATION OF MEDICAL SERVICE

    Nov 1, 2008, 00:00

  • PND27 UTILIZATION PATTERNS OF ANTIEPILEPTIC DRUGS- AN ITALIAN PRESCRIPTION DATABASE ANALYSIS

    Nov 1, 2008, 00:00

  • PRS14 COST OF ALLERGIC RHINITIS IN PEDIATRIC PATIENTS IN MEXICO

    Nov 1, 2008, 00:00

  • PSS13 HAIR LOSS- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • EE4 CAREER INTERRUPTIONS AND SICK LEAVES AMONG FIBROMYALGIA PATIENTS

    Nov 1, 2008, 00:00

  • PMH53 PREDICTIVE FACTORS OF RECURRENCE AND BIPOLAR DISORDER MANAGEMENT IN SPAIN- A PROSPECTIVE COHORT STUDY BASELINE ASSESSMENT

    Nov 1, 2008, 00:00

  • PDB63 EFFECTS OF DOSING REGIMEN ON RESOURCE UTILIZATION AND COSTS IN MEDICAID ENROLLED TYPE 2 DIABETES MELLITUS PATIENTS

    Nov 1, 2008, 00:00

  • PIN30 COST-EFFECTIVENESS ANALYSIS OF DROTRECOGIN ALFA (ACTIVATED; DAA) AS A TREATMENT FOR SEVERE SEPSIS WITH MULTIPLE ORGAN FAILURE (MOF) IN POLAND

    Nov 1, 2008, 00:00

  • PCV101 PROSPECTIVE STUDY TO EVALUATE THE IMPACT OF A DISEASE EDUCATION PROGRAM OF CARDIOVASCULAR RISK CONTROL IN HYPERTENSION

    Nov 1, 2008, 00:00

  • PCV75 THE IMPACT OF POSTPRANDIAL PEAKS ON CARDIOVASCULAR COMPLICATIONS BEYONDTHE HBA1C LEVEL-A HEALTH ECONOMIC ASSESSMENT

    Nov 1, 2008, 00:00

  • PIN53 PHARMACY-IMPLEMENTED GUIDELINES ON SWITCHING FROM INTRAVENOUSTO ORAL ANTIBIOTICS- A PROSPECTIVE STUDY IN A TEACHING HOSPITAL

    Nov 1, 2008, 00:00

  • PMS49 HEALTH-RELATED QUALITY OF LIFE (HRQL) OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) PATIENTS IN GREECE- PRELIMINARY RESULTS FROM THE HEOR STUDY

    Nov 1, 2008, 00:00

  • PMS6 PREVALENCE OF FIBROMYALGIA IN FRANCE

    Nov 1, 2008, 00:00

  • PDB18 A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETESWHO INITIATED THERAPY WITH EXENATIDE OR SITAGLIPTIN

    Nov 1, 2008, 00:00

  • PIN55 COST-EFFECTIVENESS OF DARUNAVIR/RITONAVIR 600/100MG BID IN TREATMENT-EXPERIENCED, LPV/R-NAVE, PI-RESISTANT, HIV-INFECTED ADULTS IN THE UNITED KINGDOM, BELGIUM, ITALY AND SWEDEN

    Nov 1, 2008, 00:00

  • PMS56 FIBROMYALGIA MOLDOFSKY QUESTIONNAIRE (FMQ)- VALIDATION OF A TOOL TO AID DIAGNOSIS

    Nov 1, 2008, 00:00

  • PMC3 OVERCOMING THE FINAL HURDLE- COMMUNICATING THE COST EFFECTIVENESS OF A NEW DRUG

    Nov 1, 2008, 00:00

  • PCN72 THE IMPACT OF INITIAL TREATMENT CHOICE AND DISEASE PROGRESSION ON THE ECONOMIC BURDEN OF PATIENTS AND THEIR CAREGIVERS-A LONGITUDINAL STUDY OF STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)

    Nov 1, 2008, 00:00

  • PCV2 UNDERUSE OF STATINES AMONG HIGH RISK PATIENTS

    Nov 1, 2008, 00:00

  • PCN31 ECONOMIC EVALUATION OF CLODRONATE AND ZOLENDRONATE IN PATIENTS DIAGNOSED WITH METASTATIC BONE DISEASE FROM THE PERSPECTIVE OF THIRD PARTY PAYORS IN BRAZIL

    Nov 1, 2008, 00:00

  • PRS18 DIFFERENCES IN TREATMENT COSTS AND RESOURCE UTILIZATION AMONG COPD PATIENTS TREATED WITH ALBUTEROL MDI OR LEVALBUTEROL MDI

    Nov 1, 2008, 00:00

  • PCN96 ASSOCIATION BETWEEN RESPONDENT- AND PRACTICE-RELATED CHARACTERISTICS AND RADIATION ONCOLOGY STAFF-REPORTED BURDEN ON MUCOSITIS MANAGEMENT FOR HEAD AND NECK CANCER (HNC) PATIENTS

    Nov 1, 2008, 00:00

  • PCV24 BUDGET IMPACT OF GUIDELINE ADHERENT THERAPY IN ACUTE CORONARY SYNDROME (ACS) IN GERMANY

    Nov 1, 2008, 00:00

  • PSS26 PHARMACOECONOMIC EVALUATION OF RANIBIZUMAB IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN AUSTRIA

    Nov 1, 2008, 00:00

  • PHP60 COMPARISON OF THE HEALTH ECONOMIC GUIDELINES OF THE CZECH REPUBLIC, HUNGARY, POLAND AND THE SLOVAK REPUBLIC

    Nov 1, 2008, 00:00

  • PRS33 FACTORS AFFECTING QUALITY OF LIFE OF ASTHMATIC AND COPD PATIENTS

    Nov 1, 2008, 00:00

  • PG115 COSTS OF CROHNS DISEASE WITHIN THE GERMAN STATUTORY HEALTH INSURANCE

    Nov 1, 2008, 00:00

  • PMH39 RELATIONSHIP BETWEEN CLINICAL OUTCOMES AND PATIENTS REPORTED OUTCOMES IN SCHIZOPHRENIA- THE CONTRIBUTION OF THE EQ-5D

    Nov 1, 2008, 00:00

  • HP2 NEONATAL INTENSIVE CARE UNITS (NICUS) IN GREECE- FACTORS AFFECTING THE LENGTH OF STAY (LOS) OF THE NEONATES AND THE DRIVERS OF COST

    Nov 1, 2008, 00:00

  • PND22 ELICITING UTILITY SCORES FOR HEALTH STATES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME

    Nov 1, 2008, 00:00

  • PCV80 TISSUE ENGINEERING OF VALVEDVENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONICVENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS ...

    Nov 1, 2008, 00:00

  • PIN51 EVALUATION OF SEPSIS MANAGEMENT AND OUTCOMES AT A LARGE INNER-CITY ACADEMIC MEDICAL CENTER IN THE SURVIVING SEPSIS CAMPAIGN ERA

    Nov 1, 2008, 00:00

  • PSS46 MELANOTIC TUMOURS- EVALUATION OF SELF-PERCEIVED STRESS AND QUALITY OF LIFE

    Nov 1, 2008, 00:00

  • PCV99 A CROSS-NATIONAL COMPARISON ON PRICES OF PHARMACEUTICAL PRODUCT

    Nov 1, 2008, 00:00

  • PSY31 ECONOMIC IMPACT OF THE FABRY-ANDERSON DISEASE TREATMENT

    Nov 1, 2008, 00:00

  • PMC13 ESTIMATING COST-OF-ILLNESS USING GENERALIZED LINEAR MODELS- AN ALTERNATIVE TO THE SMEARING APPROACH

    Nov 1, 2008, 00:00

  • PSY15 ECONOMIC IMPLICATIONS OF IRON CHELATION IN PATIENTS WITH REFRACTORY ANEMIA RELATED TO MYELODYSPLASTIC SYNDROME

    Nov 1, 2008, 00:00

  • PMH36 WHAT DO PATIENTS WITH SCHIZOPHRENIAWANT OUT OF THEIR MEDICATION? IDENTIFYING PATIENT REPORTED 'PROCESSES' IN MENTAL HEALTH

    Nov 1, 2008, 00:00

  • PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER- A UK PERSPECTIVE

    Nov 1, 2008, 00:00

  • PDB13 REMUBURSEMENT OF LONG-ACTING INSULIN ANALOGS IN POLAND- A BUDGT IMPACT ANALYSIS

    Nov 1, 2008, 00:00

  • PMS23 INITIAL COMBINATION THERAPY WITH INFLIXIMAB VERSUS SEQUENTIAL DMARD MONOTHERAPY- A COST-EFFECTIVENESS MODEL BASED ON THE BEST STUDY

    Nov 1, 2008, 00:00

  • PDB17 A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETESWHO INITIATED THERAPY WITH EXENATIDE OR INSULIN GLARGINE

    Nov 1, 2008, 00:00

  • PSS58 A SCORING SYSTEM FOR QUALITY OF CARE EVALUATION. A COMMUNITY-BASED STUDY OF CHRONIC LEG ULCERS IN NORTH GERMANY

    Nov 1, 2008, 00:00

  • IN2 MODELING LONG-TERM MORTALITY AND MORBIDITY IMPACT WITH ENTECAVIR TREATMENT IN CHB PATIENTS IN BELGIUM

    Nov 1, 2008, 00:00

  • PCN34 PHARMAECONOMIC EVALUATION OF THE USE OF ERLOTINIB IN NON-SMALL CELLS LUNG CANCER (NSCLC) WITH FAILURE TO PREVIOUS CHEMOTHERAPY

    Nov 1, 2008, 00:00

  • PMC57 DISCONTINUOUS COST MEASUREMENT- HOWTO FILL IN THE GAPS?

    Nov 1, 2008, 00:00

  • PND30 NATIONAL GUIDELINE FOR MULTIPLE SCLEROSIS TREATMENT IN BRAZILIAN PUBLIC HEALTH- AN ANALYSIS OF TREATMENT PATTERNS AND BUDGET IMPACT

    Nov 1, 2008, 00:00

  • PMH55 A COMPARISON OF PERSISTENCE AND HEALTH CARE COSTS RELATED TO DIFFERENT TREATMENT STRATEGIES AFTER INITIAL ESCITALOPRAM 10MG IN MAJOR DEPRESSIVE DISORDER

    Nov 1, 2008, 00:00

  • PDB28 DIABETES MELLITUS BURDEN AND RELATIONSHIP WIHTHE DEGREE OF PATIENTxS GLYCEMIC CONTROL

    Nov 1, 2008, 00:00

  • PUK12 A COST-UTILITY ANALYSIS OF SOLIFENACIN 5 MG AND 10 MGVERSUS FESOTERODINE 4 MG AND 8 MG IN THE PHARMACOLOGICAL TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER (OAB) IN THE UK NHS

    Nov 1, 2008, 00:00

  • PIH3 EPIDEMIOLOGICAL SURVEILLANCE OF CONGENITAL MALFORMATIONS IN 52,744 BIRTHS COLOMBIAN BETWEEN APRIL 2001 AND JANUARY 2008

    Nov 1, 2008, 00:00

  • PSY50 ASSESSING THE VALUE OF 24-HOUR CHRONIC PAIN CONTROL FROM THE PATIENT PERSPECTIVE- DO EXISTING PATIENT-REPORTED OUTCOMES INSTRUMENTS ADEQUATELY COVER THE RELEVANT CONCEPTS RELATED TO 24-HOUR CHRONIC PAIN CONTROL?

    Nov 1, 2008, 00:00

  • PSS57 RETROSPECTIVE CHART REVIEW TO ASSESS IMPLEMENTATION OF NICE GUIDANCE ON THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH CHRONIC PLAQUE PSORIASIS

    Nov 1, 2008, 00:00

  • PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY

    Nov 1, 2008, 00:00

  • PMC27 DO LIKERT-TYPE SCALE AND VISUAL ANLOGUE SCALE MEASURE THE SAME QUALITY OF LIFE?

    Nov 1, 2008, 00:00

  • PSY59 A POPULATION STUDY ON THE AGE-SPECIFIC RELATIONSHIP BETWEEN BODY MASS INDEX, METABOLIC DISORDERS, AND UTILIZATION OF AMBULATORY SERVICES

    Nov 1, 2008, 00:00

  • MS2 LINGUISTIC VALIDATION OF SIX QUALITY OF LIFE QUESTIONNAIRES FOR FIBROMYALGIA PATIENTS IN TWELVE LANGUAGES

    Nov 1, 2008, 00:00

  • PCN11 BUDGET IMPACT ANALYSIS OF DIFFERENT TREATMENT PROTOCOLS FORTRASTUZUMAB

    Nov 1, 2008, 00:00

  • PDB46 DIABETES RELATED QUALITY OF LIFE IN PORTUGUESE PATIENTS

    Nov 1, 2008, 00:00

  • PG119 THE COST-UTILITY OF LIVER DISEASE DIAGNOSIS- ASSESSING GP DECISIONS FOR PATIENTS WITH ABNORMAL LIVER FUNCTION TESTS AND NO OBVIOUS LIVER DISEASE

    Nov 1, 2008, 00:00

  • PMS46 DEVELOPMENT OF A SPECIFIC TOOL TO EVALUATE WOMENS ADHERENCE TO OSTEOPOROSIS TREATMENT

    Nov 1, 2008, 00:00

  • PCV29 ESTIMATING THE BUDGET IMPACT OF DABIGATRAN ETEXILATE IN THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWINGTOTAL HIP OR KNEE REPLACEMENT SURGERY- AN INTERACTIVE MODEL FOR LOCAL HEALTH ECONOMIES IN THE UK

    Nov 1, 2008, 00:00

  • PMC43 USE OF AND COMPLIANCE WITH ELECTRONIC PATIENT REPORTED OUTCOMES WITHIN CLINICAL DRUGTRIALS

    Nov 1, 2008, 00:00

  • PCN105 MEDICARE PART DS MARKET IMPACT ON UTILIZATION, AVERAGE RETAIL PRICE AND OUT-OF-POCKET SPENDING FOR ORAL CHEMOTHERAPEUTICS AND A COMPARATIVE MARKET BASKET OF DRUGS

    Nov 1, 2008, 00:00

  • PRS32 SYMPTOMS AND IMPACT OF SYMPTOMS AS REPORTED BY ASTHMA PATIENTS

    Nov 1, 2008, 00:00

  • Author Index

    Nov 1, 2008, 00:00

  • PHC5 A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN THE NETHERLANDS

    Nov 1, 2008, 00:00

  • PHC8 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT IN THE UK AND SPAIN

    Nov 1, 2008, 00:00

  • PCN108 DEVELOPMENT OF AN INTERACTIVE MODEL OF FINANCIAL ACCESS TO CANCERTHERAPY

    Nov 1, 2008, 00:00

  • PHP18 COMPARISON OF COST/QALY RATIO IN DIAGNOSTIC AND THERAPEUTIC DEVICES OR DRUGS

    Nov 1, 2008, 00:00

  • PMS48 PATIENT EXPECTATIONS IN HEALTH RELATED QUALITY OF LIFE OUTCOMES IN TOTAL JOINT REPLACEMENT

    Nov 1, 2008, 00:00

  • PSY46 PATIENT-REPORTED OUTCOMES (PRO) AND ECONOMICS OF MIGRAINE IN GERMANY

    Nov 1, 2008, 00:00

  • PHP19 REGIONAL MARKET ACCESS IN EQUALITIES FOR NEW ONCOLOGY DRUGS IN SPAIN

    Nov 1, 2008, 00:00

  • PUK22 FACTORS ASSOCIATED WITH PERCEIVED SATISFACTION IN HEMODYALISIS PATIENTS

    Nov 1, 2008, 00:00

  • PCV56 AN ECONOMIC ANALYSIS OF INDUCTION OF LABOR AND EXPECTANT MANAGEMENT INWOMEN WITH PREGNANCYINDUCED HYPERTENSION OR PREECLAMPSIA AT TERM (HYPITAT TRIAL)

    Nov 1, 2008, 00:00

  • PCN73 DEVELOPING A COMPREHENSIVE COSTS TOOLKIT TO FACILITATE ECONOMIC EVALUATIONS OF CANCER CARE IN FRANCE

    Nov 1, 2008, 00:00

  • PCV25 BUDGET IMPACT ANALYSIS OF THROMBOLYSIS FOR STROKE- A DISCRETE EVENT SIMULATION MODEL

    Nov 1, 2008, 00:00

  • PG120 ASSESSING THE COST AND EFFECTIVENESS OF TERLIPRESSIN COMPARED WITH SOMATOSTATIN FOR THE TREATMENT OF BLEEDING OESOPHAGEAL VARICES IN SPAIN

    Nov 1, 2008, 00:00

  • PDB55 PSYCHOMETRIC STRENGTH OF CURRENT TREATMENT SATISFACTION QUESTIONNAIRES IN NON-INSULIN TREATED TYPE 2 DIABETES

    Nov 1, 2008, 00:00

  • PSS47 A TOPIC DERMATITIS AND THERMAL THERAPY- EVALUATION IN CHILDREN UNDER 15

    Nov 1, 2008, 00:00

  • PCN63 METASTATIC COLORECTAL CANCER- MEDICAL COSTS OF FIRST LINE INFUSIONAL 5-FLUOROURACIL OR ORAL CAPECITABINE IN ITALIAN PATIENTS

    Nov 1, 2008, 00:00

  • PMH26 ONE YEAR PROSPECTIVE HEALTH CARE AND NON-HEALTH CARE RESOURCES USE AND COST STUDY IN PATIENTS WITH DEMENTIA OF ALZHEIMER TYPE- A SPANISH PERSPECTIVE

    Nov 1, 2008, 00:00

  • PHC12 COMPARING TIME AND SUPPLIES USAGE ASSOCIATED WITH A NEW SKIN CLOSURE DEVICE VS. STANDARD OF CARE WOUND CLOSURE FOR ABDOMINOPLASTY SURGERY IN THE NETHERLANDS

    Nov 1, 2008, 00:00

  • PSS54 EVALUATION OF TREATMENT SATISFACTION WITH ETANERCEPT VERSUS ALTERNATIVE TREATMENTS FOR PSORIASIS- A PATIENT SURVEY ACROSS NINE EUROPEAN COUNTRIES

    Nov 1, 2008, 00:00

  • PCN93 THE IMPACT OF A COST ATTRIBUTE ON PREFERENCES

    Nov 1, 2008, 00:00

  • PCV62 THE BURDEN OF ACUTE CORONARY SYNDROMES IN AUSTRALIA

    Nov 1, 2008, 00:00

  • PSS17 SENSITIVE SKINS IN BELGIUM- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • PCV52 COST-UTILITY ANALYSIS OF HOMETELEMONITORING IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE

    Nov 1, 2008, 00:00

  • PSY27 HEALTH CARE AND NON-HEALTH CARE RESOURCES UTILIZATION AND RELATED COSTS IN SUBJECTS WITH REFRACTORY PAIN ASSOCIATED TO NECK PAIN- A POST-HOC ANALYSIS OF THE EFFECT OF PREGABALIN IN A 12-WEEK PROSPECTIVE STUDY UNDER ROUTINE MEDICAL PRA ...

    Nov 1, 2008, 00:00

  • PMH4 EFFICACY AND SAFETY OF ORAL A TYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA- A META-ANALYSIS INCLUDING PALIPERIDONE EXTENDED-RELEASE

    Nov 1, 2008, 00:00

  • PDB56 IDENTIFYING FACTORSTHAT AFFECT PATIENTS WILLINGNESS TO PAY FOR INHALED INSULIN

    Nov 1, 2008, 00:00

  • PCV39 COST-EFFECTIVENESS OF NIASPANVERSUS ZETIA AS ADD-ON TREATMENTTO STATIN THERAPY IN HIGH-RISK PATIENTS

    Nov 1, 2008, 00:00

  • PRS11 COST-EFFECTIVENESS OF INCREASING MAINTENANCE DOSES WITH BUDESONIDE/FORMOTEROL MAINTENANCE RELIEVER THERAPY

    Nov 1, 2008, 00:00

  • CASE3 A CHANGE IN REIMBURSEMENT STRATEGY IN ICELAND- AIMING AT VALUE-BASED PRICING

    Nov 1, 2008, 00:00

  • QL1 AGGREGATION OF DATA FROM MULTIPLE LANGUAGES AND CULTURES- REPORT FROM THE ISPOR TASK FORCE ON TRANSLATION AND LINGUISTIC VALIDATION

    Nov 1, 2008, 00:00

  • PSS50 DEVELOPMENT OF AN INSTRUMENT FOR ASSESSING HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC URTICARIA

    Nov 1, 2008, 00:00

  • PUK11 A COST-UTILITY ANALYSIS OF SOLIFENACIN 5 MG AND SOLIFENACIN 10 MGVERSUS TOLTERODINE ER 4 MG IN THE PHARMACOLOGICAL TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER (OAB)

    Nov 1, 2008, 00:00

  • PIH14 COSTS AND OUTCOMES ASSOCIATED WITH IN VITRO FERTILISATION (IVF) OR INTRACYTOPLASMIC SPERM INJECTION (ICSI) USING RECOMBINANT FOLLICLE STIMULATING HORMONE (RFSH)

    Nov 1, 2008, 00:00

  • PDB4 GLYCEMIC CONTROL OF TYP-2 DIABETES IN MAKKAH SECURITY FORCES HEALTH CARE CENTER (MSFHCC), SAUDI ARABIA- A DISCRIPTIVE PILOT STUDY

    Nov 1, 2008, 00:00

  • PIH18 RELIABILITY, AND VALIDITY OF THE FATIGUE SYMPTOM INVENTORY

    Nov 1, 2008, 00:00

  • PSY9 BUDGET IMPACT OF THE USE OF OROS HYDROMORPHONE ONCE DAILY IN SEVERE CHRONIC PAIN PATIENTS IN THE GERMAN HEALTH CARE SYSTEM

    Nov 1, 2008, 00:00

  • PHP56 IMPACT OF ICU SEDATION PRACTICE ON PATIENT MORBIDITY, COST AND HOSPITAL RESOURCE USE- A SYSTEMATIC REVIEW

    Nov 1, 2008, 00:00

  • PDB64 EFFECTS OF DOSING REGIMEN ON MEDICATION USE BEHAVIOR IN MEDICAID ENROLLED TYPE 2 DIABETES MELLITUS PATIENTS

    Nov 1, 2008, 00:00

  • PHP45 THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE

    Nov 1, 2008, 00:00

  • PDB32 MEDICAL COSTS ATTRIBUTABLE TO OBESITY IN PATIENTS WITH DIABETES MELLITUS AMONG U.S.ADULTS

    Nov 1, 2008, 00:00

  • PMS40 COST-EFFECTIVENESS ANALYSIS OF ANNUAL DOSE OF ZOLEDRONIC ACID VERSUS ORALLY ADMINISTERED BISPHOSPHONATES IN PREVENTION OF OSTEOPOROTIC FRACTURES IN CZECH POST-MENOPAUSALWOMEN

    Nov 1, 2008, 00:00

  • PCN58 MEDICAL RESOURCE CONSUMPTION RELATED TO THE TREATMENT OF IRINOTECAN REFRACTORY ADVANCED COLORECTAL CANCER PATIENTS

    Nov 1, 2008, 00:00

  • PG12 UNCONTROLLED GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)- FINDINGS FROM A UK MULTICENTRE, CROSS-SECTIONAL STUDY

    Nov 1, 2008, 00:00

  • PCV60 TWO-YEAR HOSPITALIZATION RATES AND ASSOCIATED COSTS IN PATIENTS FROM GERMANY WITH PERIPHERAL ARTERIAL DISEASE- RESULTS FROMTHE REDUCTION OF AT HEROTHROMBOSIS FOR CONTINUED HEALTH (REACH) REGISTRY

    Nov 1, 2008, 00:00

  • PMH29 HEALTH CARE RESOURCE UTILIZATION AND COSTS OF MILD, MODERATE, AND SEVERE DEPRESSION IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PCV117 COMPARATIVE ANALYSIS OF HEALTHTECHNOLOGY ASSESSMENTS (HTA) OF DRUG ELUTING STENTS (DES)

    Nov 1, 2008, 00:00

  • PHC1 TREATMENT OF DISCOGENIC LOW BACK PAIN WITH INTRADISCAL ELECTROTHERMAL THERAPY [IDET], A MINIMALLY INVASIVE, LOW COST ALTERNATIVE TO OPEN SURGERY- A PROSPECTIVE 24-MONTH OUTCOMES STUDY IN 50 CONSECUTIVE PATIENTS

    Nov 1, 2008, 00:00

  • PCV110 THE POTENTIAL ECONOMIC IMPACTS OF RECONFIGURING TIA CARE IN THE UK

    Nov 1, 2008, 00:00

  • PCN5 TREATMENT EFFECT OF RITUXIMAB, FLUDARABINE AND CYCLOPHOSPHAMIDE (R-FC) VERSUS FC IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IN AN OBSERVATIONAL SETTING- AN INVESTIGATION OF PROGNOSTIC FACTORS AND LIFETIME HEALTH OUTCOMES

    Nov 1, 2008, 00:00

  • PRS19 RATES OF DISCONTINUATION AMONG COMMONLY PRESCRIBED MEDICATIONS IN THE US

    Nov 1, 2008, 00:00

  • PHP17 SOURCES OF INFORMATION ON DRUGS USED BY GENERAL PRACTITIONERS IN POLAND

    Nov 1, 2008, 00:00

  • PSS30 COST OF SPECTACLES AFTER CATARACT SURGERY IN THE NETHERLANDS

    Nov 1, 2008, 00:00

  • PCV91 IMPACT OF CATHETER ABLATION VERSUS ANTIARRHYTHMIC DRUGS ON QUALITY OF LIFE IN PATIENTS WITH A TRIAL FIBRILLATION

    Nov 1, 2008, 00:00

  • PMH34 WORKPLACE BURDEN OF MILD, MODERATE, AND SEVERE DEPRESSION IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PMC49 COMPARISON OF HEALTH LOCUS OF CONTROL BETWEEN PHYSICIANS AND THE GENERAL PUBLIC- MULTI-GROUP STRUCTURAL EQUATION MODELING

    Nov 1, 2008, 00:00

  • PDB68 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN SWEDEN

    Nov 1, 2008, 00:00

  • PIN13 ECONOMIC ANALYSIS OF MICAFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B FOR TREATMENT OF CANDIDAEMIA AND INVASIVE CANDIDIASIS IN ITALY

    Nov 1, 2008, 00:00

  • PCV66 COST SAVINGS OF CORONARY CT ANGIOGRAPHY VS. CARDIAC CATHETERIZATION TO EVALUATE PATIENTS WITH AN ABNORMAL OR NONDIAGNOSTIC STRESS TEST

    Nov 1, 2008, 00:00

  • PCASE2 PHARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT- A CASE STUDY OF CETUXIMAB AT A MAJOR ACADEMIC CANCER CENTER

    Nov 1, 2008, 00:00

  • PCASE1 ESTABLISHMENT OF A COST-EFFECTIVENESS (CE) THRESHOLD AT KING HUSSEIN CANCER CENTER- IMATINIB IN CHRONIC MYELOGENOUS LEUKEMIA (CML)

    Nov 1, 2008, 00:00

  • PIH17 TURKISH CULTURAL ADAPTATION AND VALIDATION OF THE MENOPAUSE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE

    Nov 1, 2008, 00:00

  • PCN89 RACE AND SHARED DECISION MAKING AMONG PROSTATE CANCER PATIENTS, FAMILY MEMBERS AND PHYSICIANS

    Nov 1, 2008, 00:00

  • PSY48 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN RUSSIA- PATIENT-REPORTED DATA. INTERMEDIATE RESULTS. PART 2

    Nov 1, 2008, 00:00

  • PMS50 FRACTURE INCIDENCE AND CHANGES IN QUALITY OF LIFE AND BACK PAIN INWOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE- EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS) 18 MONTH RESULTS FROM PATIENTS ENROLLED IN FRANCE

    Nov 1, 2008, 00:00

  • PRS40 DECISION-MAKING IN HEALTH CARE USING COST-EFFECTIVENESS EVIDENCE-SMOKING CESSATION COMPARED TO TREATMENT OF SMOKING-RELATED DISEASES

    Nov 1, 2008, 00:00

  • PMS37 A MICROSIMULATION-BASED COST-UTILITY ANALYSIS OF RITUXIMAB (MABTHERA ) IN PATIENTS WITH RHEUMATIC ARTHRITIS IN SPAIN

    Nov 1, 2008, 00:00

  • PSY33 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH BLOODTRANSFUSION DURING INPATIENT HOSPITALIZATION- AN ANALYSIS OF THE 2004 HEALTH CARE COST AND UTILIZATION PROJECT NATIONWIDEINPATIENT SAMPLE DATABASE

    Nov 1, 2008, 00:00

  • PMC12 MODELLING THE VALUE FOR MONEY OF CLINICAL PRACTICE CHANGE- A STOCHASTIC APPLICATION IN DIABETES CARE

    Nov 1, 2008, 00:00

  • PCV113 PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION- WHOARE THE 'UNTREATED PATIENTS' IN HOSPITALS WITH CATH LAB?

    Nov 1, 2008, 00:00

  • PCV36 COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF TRITACE COMB (RAMIPRIL/HCTZ) IN TREATMENT OF HYPERTENSION IN POLAND

    Nov 1, 2008, 00:00

  • PMS10 PREVALENCE OF FIBROMYALGIA IN SPAIN

    Nov 1, 2008, 00:00

  • PSY45 PATIENT ACCEPTABLE SYMPTOM STATE (PASS) IN EUROPEAN PATIENTS WITH MODERATE-SEVERE PLAQUE PSORIASIS

    Nov 1, 2008, 00:00

  • PHP15 DETERMINANTS OF PHARMACEUTICAL CONSUMPTION IN A GENERAL POPULATION

    Nov 1, 2008, 00:00

  • PIH13 ASSESSING THE INCREASED MATERNAL AND NEONATAL HEALTH CARE COSTS ASSOCIATED WITH PREECLAMPSIA

    Nov 1, 2008, 00:00

  • PMC1 COLLECTING REAL DATA FROM REAL PATIENTS

    Nov 1, 2008, 00:00

  • PDB26 COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC

    Nov 1, 2008, 00:00

  • PIN6 AN OBSERVATIONAL HEALTH ECONOMIC ANALYSIS OF THE COMBINED THERAPY WITH PEGINTERFERON ALPHA-2A (PEGASYS) AND RIBAVIRIN IN PATIENTS WITH CHRONIC C HEPATITIS (CHC) IN A REAL LIFE SETTING

    Nov 1, 2008, 00:00

  • PCV54 A EUROPEAN MULTI-COUNTRY COMPARISON OF THE COST-EFFECTIVENESS OF IODIXANOL VERSUS IOHEXOL BASED ON THE RESULTS OF THE NEPHRIC CLINICAL TRIAL

    Nov 1, 2008, 00:00

  • QL12 FRENCH NORMATIVE REFERENCE DATA FOR THE QUALITY OF LIFE ASSESSMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS (QOL-AGHDA) QUESTIONNAIRE

    Nov 1, 2008, 00:00

  • PND18 RUFINAMIDE IN THE ADJUNCTIVE TREATMETN OF LENNOX-GASTAUT SYNDROME (LGS)- A COST EFFECTIVENESS ANALYSIS

    Nov 1, 2008, 00:00

  • MH1 HOW MUCH SHOULDWE BE PREPARED TO PAY FOR PSYCHOSOCIAL INTERVENTIONS FOR PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)?

    Nov 1, 2008, 00:00

  • PCN32 ECONOMIC ANALYSIS OF CHEMO RADIOTHERAPY IN HEAD AND NECK CANCER

    Nov 1, 2008, 00:00

  • PCV123 THE CARDIOVASCULAR PREVENTION MODEL (CPM), A GENERICALLY APPLICABLE MODEL FOR UNDERTAKING COST-EFFECTIVENESS ANALYSES OF PREVENTIVE INTERVENTIONS

    Nov 1, 2008, 00:00

  • PCN35 ECONOMIC EVALUATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) CHEMOTHERAPY REGIME WITH OR WITHOUT RITUXIMAB (R) IN THE 2ND LINE TREATMENT OF FOLLICULAR NON-HODGIN LYMPHOMA

    Nov 1, 2008, 00:00

  • EE3 VARIATION IN DIRECT MEDICAL COSTS BY DISEASE SEVERITY AMONG PERSONS WITH CHRONIC HEPATITIS CVIRUS

    Nov 1, 2008, 00:00

  • HP4 THE IMPACT OF A MEDICAID EXPANSION TO INCLUDE POPULATION WITH LOW INCOME ON THE PREVENTABLE HOSPITALIZATIONS

    Nov 1, 2008, 00:00

  • PRS39 GIVING-UP SMOKING- PREDICTIVE FACTORS OF SMOKING CESSATION AND ATTEMPTS TO STOP IN A FRENCH COHORT

    Nov 1, 2008, 00:00

  • PHP51 OTHER HEALTHTECHNOLOGY ASSESSMENT GROUPS OPERATING IN ENGLAND; ITS NOT JUST NICETHAT NEEDS TO BE TAKEN INTO CONSIDERATION

    Nov 1, 2008, 00:00

  • PMC22 THE IMPACT OF COMORBIDITY BURDEN AND AGE ON PREFERENCE-BASED HRQL IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PIH12 INPATIENT LENGTH OF STAY AND TOTAL COSTS OF ILLNESSES OF PRESSING CONCERN FOR ASIAN-AMERICAN AND PACIFIC ISLANDERWOMEN IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PDB23 COST-EFFECTIVENESS OF SOMATROPIN (NORDITROPIN) FOR THE TREATMENT OF GROWTH HORMONE DEFICIENT (GHD) CHILDREN IN A SWEDISH SETTING

    Nov 1, 2008, 00:00

  • PCN65 A PHARMACOECONOMIC MODEL FOR THE MANAGEMENT OF CANCER PAIN- OPIOID MARKET WITH OR WITHOUT OROS HYDROMORPHINE IN TURKEY

    Nov 1, 2008, 00:00

  • PMH13 COST-UTILITY AND BUDGET IMPACT OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND

    Nov 1, 2008, 00:00

  • PCV79 ECONOMIC EVALUATION OF IRBESARTAN IN GREECE

    Nov 1, 2008, 00:00

  • PMH16 THE COST-EFFECTIVENESS OF PALIPERIDONE ER IN ACUTE PHASE OF SCHIZOPHRENIA IN TURKEY

    Nov 1, 2008, 00:00

  • PG133 A POPULATION-BASED SURVEY TO ASSESS IMPACT OF TROUBLESOME SYMPTOMS IN GASTROESOPHAGEAL REFLUX DISEASE ON WORK PRODUCTIVITY

    Nov 1, 2008, 00:00

  • PCN91 TREATMENT PREFERENCE AND WILLINGNESS-TO-PAY (WTP) FOR METHYLNALTREXONE, A NOVEL PERIPHERAL OPIOID ANTAGONIST FOR OPIOID INDUCED CONSTIPATION

    Nov 1, 2008, 00:00

  • PSY19 MEDICAL AND COST EFFECTIVENESS OF BARIATRIC SURGERY IN OBESITY. RESULTS OF AN HTA COMMISIONED BY THE GERMAN AGENY FOR HEALTHTECHNOLOGY ASSESSMENT

    Nov 1, 2008, 00:00

  • PMS61 SHORT-TERM OUTCOMES AND HRQOL AFTER PEDIATRIC EMERGENCY DEPARTMENT (PED) TREATMENT OF MINOR INJURY- A PILOT STUDY

    Nov 1, 2008, 00:00

  • PMH22 IMPACT ON SCHIZOPHRENIA INPATIENT RESOURCE USE FOLLOWING SWITCHTO LONG-ACTING RISPERIDONE IN FINLAND

    Nov 1, 2008, 00:00

  • PG124 FURTHER VALIDATION OF THE GASTROINTESTINAL SHORT FORM QUESTIONNAIRE (GSFQ) IN THE SPANISH POPULATION

    Nov 1, 2008, 00:00

  • PSY35 COST-EFFECTIVENESS ANALYSIS OF THE EPOETIN TREATMENT IN PATIENTS WITH ANEMIA INDUCED BY CHEMOTHERAPY, EPICOST STUDY PRELIMINARY RESULTS (ONVIDA GROUP)

    Nov 1, 2008, 00:00

  • PIN22 COST-EFFECTIVENESS ANALYSIS OF VACCINATION AGAINST ROTAVIRUS WITH RIX4414 IN FRANCE

    Nov 1, 2008, 00:00

  • EE8 COST EFFECTIVENESS OF CAPECITABINE IN COMBINATION WITH OXALIPLATIN (XELOX) COMPARED TO FOLFOX (5-FU, LV, OXALIPLATIN) FOR THE TREATMENT OF METASTATIC CARCINOMA OF THE COLON OR RECTUM (CRC) FROM A UK NATIONAL HEALTH SERVICE (NHS) PERSPEC ...

    Nov 1, 2008, 00:00

  • PCN84 THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM CANCER PAIN ITEM BANK (PROMIS-CA PAIN)

    Nov 1, 2008, 00:00

  • PIH7 ECONOMIC ANALYSIS OF TREATMENT WITH IUI-COH VERSUS 6 MONTHS DELAY OF TREATMENT IN COUPLES WITH UNEXPLAINED SUBFERTILITY

    Nov 1, 2008, 00:00

  • PSY41 REVIEW OF HOME READINESS INSTRUMENTS TO ASSESS RECOVERY POST-SURGERY

    Nov 1, 2008, 00:00

  • PSS19 SENSITIVE SKINS IN GREECE- AN EPIDEMIOLOGICAL APPROACH

    Nov 1, 2008, 00:00

  • PCN8 QUALITY OF LIFE-ADJUSTED SURVIVAL FOR FIRST LINE TREATMENT WITH RITUXIMAB PLUS CYCLOPHOSPHAMIDE AND VINCRISTINE (CVP) VERSUS CVP ALONE FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA

    Nov 1, 2008, 00:00

  • PMS59 RESTORATIVE EFFECT OF SLEEP- VALIDATION OF THE SQA (SLEEP QUALITY ASSESSMENT)

    Nov 1, 2008, 00:00

  • PIN7 PHARMACOGENOMICS- RELEVANCE AND APPLICABILITY IN POST-GENOMIC ERA (HIV-THERAPY)

    Nov 1, 2008, 00:00

  • IN3 PHARMACOECONOMIC ANALYSIS OF ITRACONAZOLE ORAL SOLUTION IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN TURKEY

    Nov 1, 2008, 00:00

  • PCN76 HEALTH-RELATED QUALITY OF LIFE EVALUATION IN ROMANIAN CANCER PATIENTS

    Nov 1, 2008, 00:00

  • PMH14 THE COST-EFFECTIVENESS OF QUETIAPINE EXTENDED-RELEASE VERSUS OLANZAPINE FOLLOWING GENERIC RISPERIDONE IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA

    Nov 1, 2008, 00:00

  • PCV51 SINGLE PILL AMLODIPINE/ATORVASTATIN IS COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN KOREA

    Nov 1, 2008, 00:00

  • PMH49 INTERNATIONAL INVESTIGATION INTO DEPRESSION BASED ON THE STRUCTURED INTERVIEW GUIDE FOR THE HAMILTON DEPRESSION RATING SCALE (SIGH-D) AND THE CLINICIAN RATED INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY (IDS-C)

    Nov 1, 2008, 00:00

  • PHP10 PHARMACY AND HOSPITAL MARKET PERFORMANCE INDICATORS IN FINLAND 1995-2007

    Nov 1, 2008, 00:00

  • PCN14 A MODELTO DEMONSTRATE THE COMPARATIVE COSTS BETWEEN PANITUMUMAB AND CETUXIMAB FOR THIRD-LINE METASTATIC COLORECTAL CANCER PATIENTS IN ITALY

    Nov 1, 2008, 00:00

  • PUK10 ECONOMIC IMPACT OF A LOW-PROTEIN DIET AIMING TO DELAY THE HAEMODIALYSIS TREATMENT IN PATIENTS WITH CHRONIC-RENAL-FAILURE

    Nov 1, 2008, 00:00

  • PCN9 COST OF MANAGEMENTVERSUS REIMBURSEMENT COST OF THE MANAGEMENT OF PATIENTS WITH SOLIDTUMORS PRESENTING A FEBRILE NEUTROPENIA

    Nov 1, 2008, 00:00

  • PMC47 A STUDY OF THE KEY FACTORS INFLUENCING THE PATIENT SATISFACTION IN INPATIENT AND OUTPATIENT SETTINGS

    Nov 1, 2008, 00:00

  • PSS45 A TOPICAL DERMATITIS- EVALUATION OF SELF-PERCEIVED STRESS AND QUALITY OF LIFE

    Nov 1, 2008, 00:00

  • PCV77 COST EFFECTIVENESS OF HIGH DOSE ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN THE UK

    Nov 1, 2008, 00:00

  • PND28 TRENDS IN RESEARCH INTO CENTRAL NERVOUS SYSTEM DISORDERS- THE INFLUENCE OF AN AGING POPULATION

    Nov 1, 2008, 00:00

  • PCN55 MANAGAMENT COSTS OF PATIENTS WITH VULVAR AND VAGINAL CANCER IN FRANCE

    Nov 1, 2008, 00:00

  • PCN22 AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN

    Nov 1, 2008, 00:00

  • MD2 COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF ENDEVOR DRUG-ELUTING STENT COMPARED TO BARE-METAL STENTS AND CORONARY ARTERY BYPASS GRAFT SURGERY IN SPAIN

    Nov 1, 2008, 00:00

  • PRS21 CAN ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) DATA FROM DIFFERENT COUNTRIES BE COMBINED FOR ANALYSES?

    Nov 1, 2008, 00:00

  • PG15 A BUDGET IMPACT ANALYSIS FOR DETERMINING THE COSTS OF INCREASED PANTOPRAZOL IV PRESCRIPTION FOR THE MANAGEMENT OF PEPTIC ULCER IN SPAIN

    Nov 1, 2008, 00:00

  • PCN69 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FIRST-LINE CHEMOTHERAPY TREATMENT REGIMENS IN SPANISH PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA

    Nov 1, 2008, 00:00

  • PMH52 PILOT SURVEY OF ADVERSE EVENT MANAGEMENT ASSOCIATED WITH ANTIPSYCHOTIC USE- THE NEGLECTED DIMENSION IN RESOURCE USE IMPLICATIONS (A UK PERSPECTIVE)

    Nov 1, 2008, 00:00

  • PMS70 COST-EFFECTIVENESS OF ETANERCEPT VS. RITUXIMAB IN THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN COLOMBIA

    Nov 1, 2008, 00:00

  • PHC13 CHANGINGTHE SURGICALWOUND CLOSURE MANAGEMENT PATHWAY- TIME AND SUPPLIES WITH PRINEO VS. STANDARD OF CARE FOR ABDOMINOPLASTY SURGERY IN GERMANY

    Nov 1, 2008, 00:00

  • EE2 STANDARDIZED TYPE 2 DIABETES COMPLICATION COSTS FROM US COMMERCIAL PAYERS TO BE USED IN MODELING THE LONG-TERM ECONOMIC OUTCOMES OF DIABETES COMPLICATIONS

    Nov 1, 2008, 00:00

  • PG111 A COST-EFFICACY ANALYSIS MODEL FOR PHYSICIAN ADMINISTERED ANTI-TUMOR NECROSIS FACTOR AGENTS IN CROHNS DISEASE

    Nov 1, 2008, 00:00

  • PCV45 COST-EFFECTIVENESS OF EPLERENONE IN PATIENTS WITH HEART FAILURE AFTER ACUTE MYOCARDIAL INFARCTION

    Nov 1, 2008, 00:00

  • OR4 UTILITIES SHOULD NOT BE MULTIPLIED- EVIDENCE FROM THE PREFERENCE-BASED SCORES IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PIH21 EFFICACY OF TREATMENT AND PATIENT SATISFACTION IN TREATMENT OF CLIMACTERIC DISORDERS WITH SOY ISOFLAVONES- FRENCH APPROCH

    Nov 1, 2008, 00:00

  • PG18 A COST-EFFECTIVENESS EVALUATION-RETREATMENT WITH PEGYLATED INTERFERON ALFA 2B PLUS RIBAVIRIN IN HEPATITIS C PATIENTSWHO HAVE PREVIOUSLY RECEIVED INTERFERON-BASED THERAPY AND FAILED TO ATTAIN A SUSTAINED VIROLOGICAL RESPONSE

    Nov 1, 2008, 00:00

  • PHC14 ORGAN SHORTAGE IN TRANSPLANTATION MEDICINE- WHOSEVALUES AND ON WHAT BASIS SHOULD ORGAN PROCUREMENT BE ORGANISED?

    Nov 1, 2008, 00:00

  • PUK21 CONTENTVALIDITY OF THE SUBJECTS HEALTH QUESTIONNAIRE, AND INTERNATIONAL CONSULTATION ON INCONTINENCE QUESTIONNAIRE-SHORT FORM IN PATIENTS WITH OAB

    Nov 1, 2008, 00:00

  • PMS4 COST-EFFECTIVENESS ANALYSIS OF LEFLUNOMIDE AS A TREATMENT FOR RHEUMATOID ARTHRITIS IN MEXICO

    Nov 1, 2008, 00:00

  • PSS59 IMPACT OF HEALTH CARE REGULATION ON PROSTAGLANDIN ANALOGUE PRESCRIBING IN 5 EUROPEAN COUNTRIES

    Nov 1, 2008, 00:00

  • PMS57 VALIDITY AND RESPONSIVENESS OF THE WORK PRODUCTIVITY SURVEY- A NOVEL DISEASE-SPECIFIC INSTRUMENT ASSESSINGWORK PRODUCTIVITY WITHIN AND OUTSIDE THE HOME IN SUBJECTS WITH RHEUMATOID ARTHRITIS

    Nov 1, 2008, 00:00

  • PRS12 COST-EFFECTIVENESS ANALYSIS OF SYMBICORT SMART VERSUS FIXED COMBINATION TREATMENTS IN FINLAND

    Nov 1, 2008, 00:00

  • PMH62 ECONOMIC OUTCOMES OF CO-TREATMENT OF INSOMNIA AND MAJOR DEPRESSIVE DISORDER (MDD) WITH ESZOPICLONE AND FLUOXETINE VERSUS FLUOXETINE TREATMENT ALONE

    Nov 1, 2008, 00:00

  • PCV50 COST-EFFECTIVENESS OF RULING OUT DEEPVENOUS THROMBOSIS IN PRIMARY CARE VERSUS CARE AS USUAL

    Nov 1, 2008, 00:00

  • PMS8 PREVALENCE OF FIBROMYALGIA IN ITALY

    Nov 1, 2008, 00:00

  • PSS29 SOCIETAL COSTS OF SEVERE CHRONIC HAND ECZEMA (CHE) IN GERMANY

    Nov 1, 2008, 00:00

  • PIN38 THE ECONOMIC BURDEN OF HCV AND HBV CO-INFECTION- EVIDENCE FROM UNITED STATES MANAGED CARE DATA

    Nov 1, 2008, 00:00

  • PMH9 TOLERABILITY OF A TYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER- A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS

    Nov 1, 2008, 00:00

  • PSY54 UNDERSTANDING PATIENT PERCEPTION OF THE BIOENTERICS INTRAGASTRIC SYSTEM FOR WEIGHT REDUCTION

    Nov 1, 2008, 00:00

  • HP1 ANALYSIS OF THE ORPHAN DRUG DESIGNATIONS AND APPROVALS GRANTED BY THE EMEA AND THE USA FDA BETWEEN 2000 AND 2007

    Nov 1, 2008, 00:00

  • PMH43 THE SPANISH VERSION OF THE TOOL QUESTIONNAIRE- A USEFUL MEASURE FOR EVALUATING THE HRQOL AND UTILITIES FROM SCHIZOPHRENIC AND BIPOLAR PATIENTS

    Nov 1, 2008, 00:00

  • PMS12 THE ROLE OF DIFFERENT CO-MORBIDITIES IN THE EVALUATION OF CORRELATION BETWEEN CERTAIN RISK FACTORS AND THE ONE YEAR MORTALITY FOLLOWING FEMORAL NECK FRACTURE

    Nov 1, 2008, 00:00

  • PCV55 PHARMACOECONOMIC EVALUATION OF TREATMENT WITH PROCORALAN PREPARATION COMPARED TO INVASIVE TREATMENT

    Nov 1, 2008, 00:00

  • PRS35 CHALLENGING ASTHMA MANAGEMENT WITH THE USE OF LABA/ICS COMBINATION VIA ATURBUHALER DEVICE, BOTH FOR MAINTENANCE AS WELL AS RELIEF, AND IT WELL-BEING IN GREECE

    Nov 1, 2008, 00:00

  • PIH5 INCIDENCE OF MAJOR MALFORMATIONS IN INFANTS FOLLOWING ANTIDEPRESSANT EXPOSURE IN PREGNANCY- RESULTS OF A LARGE PROSPECTIVE COHORT STUDY

    Nov 1, 2008, 00:00

  • PCN107 NEW OPPORTUNITIES FOR DRUG OUTCOMES RESEARCH IN CANCER PATIENTS- VALIDATION OF THE LINKAGE OF THE EINDHOVEN CANCER REGISTRY AND THE PHARMO RECORD LINKAGE SYSTEM

    Nov 1, 2008, 00:00

  • PND15 THE INDIRECT COST BURDEN OF EPILEPSY IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PDB52 A SELF-MANAGEMENT PROFILE FOR PATIENTS WITH TYPE-2 DIABETES

    Nov 1, 2008, 00:00

  • AR2 A COST EFFECTIVENESS ANALYSIS OF INFLIXIMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN SWEDEN, BASED ON DATA FROM THE STURE REGISTRY

    Nov 1, 2008, 00:00

  • PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY- A PROBABILISTIC SENSITIVITY ANALYSIS

    Nov 1, 2008, 00:00

  • PG17 AN ECONOMIC EVALUATION OF THE TWO LEADING ALGINTE THERAPIES IN THE UK- RESULTS FROM A LARGE LONGITUDINAL DATABASE

    Nov 1, 2008, 00:00

  • EE5 COST-EFFECTIVENESS OF ATORVASTATIN IN TYPE 2 DIABETES PATIENTS- A PHARMACO-ECONOMIC ANALYSIS OF THE COLLABORATIVE ATORVASTATIN DIABETES STUDY (CARDS) IN THE BELGIAN POPULATION

    Nov 1, 2008, 00:00

  • PMC38 INFLUENCE OF DEMOGRAPHIC AND CULTURAL PREDICTORS ON EQ-5D VALUE SET IN THE POLISH POPULATION

    Nov 1, 2008, 00:00

  • PMH41 SAD BLUE DEPRESSED DAYS, HEALTH-RELATED QUALITY OF LIFE, AND HEALTH BEHAVIORS AMONGWOMEN IN A UNIVERSITY COMMUNITY

    Nov 1, 2008, 00:00

  • CN2 ESTIMATING TARGET POPULATION SIZE FOR BUDGET IMPACT- AN EPIDEMIOLOGICAL MODEL OF BREAST CANCER AND PROGRESSION TO BONE METASTASIS IN THE UK.

    Nov 1, 2008, 00:00

  • PCV13 ATTAINMENT OF MULTIPLE RECOMMENDED LIPID LEVELS FOLLOWING LIPID MODIFYING TREATMENT IN HIGH RISK PATIENTS. PRIMULA STUDY, SPAIN

    Nov 1, 2008, 00:00

  • PSY47 PATIENT-REPORTED OUTCOMES (PRO) IN SUBJECTS WITH REFRACTORY PAIN ASSOCIATED TO NECK PAIN- A POST-HOC ANALYSIS OF THE EFFECT OF PREGABALIN IN A 12-WEEK PROSPECTIVE STUDY UNDER ROUTINE MEDICAL PRACTICE CONDITIONS

    Nov 1, 2008, 00:00

  • PMC55 THE C-STATISTIC AND THE EFFICIENCY OF THE PROPENSITY SCORES MODEL- EVIDENCE FROM SIMULATED DATA

    Nov 1, 2008, 00:00

  • PSY28 HEALTH CARE AND NON-HEALTH CARE RESOURCES UTILIZATION AND RELATED COSTS IN SUBJECTS WITH REFRACTORY PAIN ASSOCIATED TO LOW BACK PAIN- A POST-HOC ANALYSIS OF THE EFFECT OF PREGABALIN IN A 12-WEEK PROSPECTIVE STUDY UNDER ROUTINE MEDICAL ...

    Nov 1, 2008, 00:00

  • PMC29 PATIENT REPORTED OUTCOMES RESEARCH IN A REAL TIME PRACTICE NETWORK

    Nov 1, 2008, 00:00

  • PCV4 COMPARISON OF THE CLINICAL AND ECONOMIC EFFECTIVENESS OF SIROLIMUS-ELUTING VERSUS BARE-METAL STENTS IN A SUBGROUP OF PATIENTS WITH AND WITHOUT DIABETES

    Nov 1, 2008, 00:00

  • PSS6 EFFECTIVENESS OF MOXIFLOXACIN IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS IN ADULTS

    Nov 1, 2008, 00:00

  • PCV104 EVALUATION OF THE PRESCRIPTION PATTERNS OF STATINS THROUGH APPROPRIATE INDICATORS IN TWO ITALIAN LOCAL HEALTH UNITS IN 2004-2006

    Nov 1, 2008, 00:00

  • PCN82 TESTING THE MEASUREMENT EQUIVALENCE OF PAPER AND INTERACTIVE VOICE RESPONSE (IVR) VERSIONS OF THE EQ-5D

    Nov 1, 2008, 00:00

  • PIN29 EFFECTIVENESS AND COST-EFFECTIVENESS OF HEPATITIS C SCREENING-A SYSTEMATIC REVIEW

    Nov 1, 2008, 00:00

  • PUK7 A TEN-YEAR HORIZON COST-EFFECTIVENESS ANALYSIS OF THE SPANISH INTEGRATED RENAL REPLACEMENT THERAPY PROGRAM

    Nov 1, 2008, 00:00

  • PSY10 ESTIMATION OF THE COSTS FOR A HEREDITARY HEMOCHROMATOSIS GENETIC SCREENING PROGRAMME PER 100.000 INDIVIDUALS UNDER 30YEARS OF AGE IN SPAIN

    Nov 1, 2008, 00:00

  • PCV37 ENOXAPARIN IS COST-SAVING AS PROPHYLACTIC THERAPY VERSUS UNFRACTIONATED HEPARIN OR NO PROPHYLAXIS IN HOSPITALISED MEDICAL PATIENTS

    Nov 1, 2008, 00:00

  • PHP48 THE EFFECTS OF NICE HTAS ON PRESCRIPTION VOLUME, AVERAGE RETAIL PRICE AND AVERAGE OUT-OF-POCKET COSTS OF DRUGS DEEMED MEDICALLY NECESSARY FOR MEDICARE PART D REIMBURSEMENT IN THE UNITED STATES

    Nov 1, 2008, 00:00

  • PCV107 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES

    Nov 1, 2008, 00:00

  • PCV111 COST-ANALYSIS OF DYSLIPOPROTEINAEMIA TREATMENTS WITHIN THE SLOVAK REPUBLIC

    Nov 1, 2008, 00:00

  • PND31 DESCRIPTIVE STUDY OF THE PHARMACOLOGICAL TREATMENTS USED IN PATIENTS WITH DEPRESSION IN PARKINSONS DISEASE (PD)

    Nov 1, 2008, 00:00

  • PIN23 COST-EFFECTIVENESS ANALYSIS OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN TAIWAN- TRANSMISSION DYNAMIC MODEL-BASED EVALUATIONS

    Nov 1, 2008, 00:00

  • PMH6 A SYSTEMATIC REVIEW ON THE EPIDEMIOLOGY AND SOCIOECONOMIC BURDEN OF BIPOLAR DISORDER IN EUROPE

    Nov 1, 2008, 00:00

  • PRS9 COST-EFFECTIVENESS MODEL OF MOXIFLOXACIN IN ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS (AECB) IN GERMANY INCLUDING THE EFFECTS OF RESISTANCE

    Nov 1, 2008, 00:00

  • EE7 ECONOMIC ANALYSIS OF PROPHYLACTIC CERVICAL CANCERVACCINATION IN ITALY- THE NATIONAL AND REGIONAL LEVEL

    Nov 1, 2008, 00:00
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149 (current)
  • 150
  • »